These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Pfaller MA; Jones RN; Doern GV; Sader HS; Kugler KC; Beach ML Diagn Microbiol Infect Dis; 1999 Apr; 33(4):283-97. PubMed ID: 10212756 [TBL] [Abstract][Full Text] [Related]
3. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance. Reyes J; Hidalgo M; Díaz L; Rincón S; Moreno J; Vanegas N; Castañeda E; Arias CA Int J Infect Dis; 2007 Jul; 11(4):329-36. PubMed ID: 17320446 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic therapeutic options for infections caused by drug-resistant Gram-positive cocci. Banwan K; Senok AC; Rotimi VO J Infect Public Health; 2009; 2(2):62-73. PubMed ID: 20701863 [TBL] [Abstract][Full Text] [Related]
5. New antimicrobial agents as therapy for resistant gram-positive cocci. Lentino JR; Narita M; Yu VL Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):3-15. PubMed ID: 17899228 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia. Yezli S; Shibl AM; Livermore DM; Memish ZA J Chemother; 2012 Jun; 24(3):125-36. PubMed ID: 22759756 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico. Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136 [TBL] [Abstract][Full Text] [Related]
8. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status. Hamilton-Miller JM; Shah S J Antimicrob Chemother; 1998 Jun; 41(6):649-53. PubMed ID: 9687104 [TBL] [Abstract][Full Text] [Related]
9. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Falagas ME; Roussos N; Gkegkes ID; Rafailidis PI; Karageorgopoulos DE Expert Opin Investig Drugs; 2009 Jul; 18(7):921-44. PubMed ID: 19548851 [TBL] [Abstract][Full Text] [Related]
10. [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci]. Kuroyama M; Okamoto E; Yago K Jpn J Antibiot; 1998 Dec; 51(12):764-78. PubMed ID: 10077775 [TBL] [Abstract][Full Text] [Related]
11. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens]. Nakashio S; Iwasawa H; Iino S; Shimada J Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Sader HS; Farrell DJ; Jones RN Int J Antimicrob Agents; 2010 Jul; 36(1):28-32. PubMed ID: 20444576 [TBL] [Abstract][Full Text] [Related]
13. Resistance problems in two university hospitals in Denmark. Jensen TG; Kolmos HJ; Siboni K Int J Antimicrob Agents; 1999 Jun; 12(1):71-3. PubMed ID: 10389651 [TBL] [Abstract][Full Text] [Related]
14. Anaerobic cocci and their resistance patterns to penicillin, cefoxitin, clindamycin and metronidazole: a Bulgarian study. Boyanova L; Osmanliev D; Petrov D; Mitov I; Usunova I; Petrov S; Minchev TZ Clin Microbiol Infect; 2000 Nov; 6(11):623-4. PubMed ID: 11168069 [No Abstract] [Full Text] [Related]
15. Mechanisms of resistance to antimicrobial drugs in pathogenic Gram-positive cocci. Mlynarczyk B; Mlynarczyk A; Kmera-Muszynska M; Majewski S; Mlynarczyk G Mini Rev Med Chem; 2010 Sep; 10(10):928-37. PubMed ID: 20370697 [TBL] [Abstract][Full Text] [Related]
16. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials]. Giglio MS; Farías O; Lafourcade M; Pinto ME Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252 [TBL] [Abstract][Full Text] [Related]
17. Emerging resistance in clinically important gram-positive cocci. Thornsberry C West J Med; 1996 Jan; 164(1):28-32. PubMed ID: 8779198 [TBL] [Abstract][Full Text] [Related]
18. Daptomycin susceptibility of 833 strains of Gram-positive cocci from a university hospital in Japan (2009-2011). Yoshizumi A; Ishii Y; Iwata M; Murakami H; Yumoto S; Yasui K; Maehara C; Fukuzawa S; Enokizono K; Tateda K Diagn Microbiol Infect Dis; 2014 Oct; 80(2):151-3. PubMed ID: 25056827 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]